Home

Basic Information

1

Trade Type

Sell

Product Name

Ozurdex

Substance

Registered Market

Specifications

  • Dosage Form: Implant intravitreal injection
  • Packaging: Box 1 sachet containing 1 device injection for use one times and 1 rod/stick cấy
  • Strength: Dexamethason 700mcg/implant
  • Standards: In-house standard
  • Shelf Life: 36 month

Documents

Drug Marketing Authorization Number
Document No.: 539110075123
Issue Date: Apr 2, 2023
Expiry Date: Apr 2, 2028
Note: 226/QĐ-QLD | 113
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Ozurdex | PharmaCountry